Video

ecancer's extensive video archive features interviews, panel discussions and conference coverage on almost every topic in oncology.

WHO and St. Jude Children’s research hospital to dramatically increase global access to childhood cancer medicine

Dr Andre Llbawi - World Health Organization (WHO) Global Childhood Cancer Initiative
WHO and St. Jude Children’s research hospital to dramatically increase global access to childhood cancer medicine ( Dr Andre Llbawi - World Health Organization (WHO) Global Childhood Cancer Initiative )
17 Dec 2021

The global platform for access to childhood cancer medicines

Dr James Downing - St. Jude Children’s Research Hospital, Memphis, USA
The global platform for access to childhood cancer medicines ( Dr James Downing -  St. Jude Children’s Research Hospital, Memphis, USA )
17 Dec 2021

Cancer medicine shortages for children around the world

Dr Carlos Rodriguez-Galindo - St. Jude Children’s Research Hospital, Memphis, USA
Cancer medicine shortages for children around the world ( Dr Carlos Rodriguez-Galindo - St. Jude Children’s Research Hospital, Memphis, USA )
17 Dec 2021

OncoAlert and ecancer round up: SABCS 2021

Dr Gil Morgan - Skåne University Hospital in Lund, Sweden
OncoAlert and ecancer round up: SABCS 2021 ( Dr Gil Morgan - Skåne University Hospital in Lund, Sweden )
16 Dec 2021

INTEGRATE study: Treatment pathways, outcomes and resource use in patients with multiple myeloma

Prof Meral Beksac and Prof Roman Hájek
INTEGRATE study: Treatment pathways, outcomes and resource use in patients with multiple myeloma ( Prof Meral Beksac and Prof Roman Hájek )
15 Dec 2021

Silver linings: a qualitative study of desirable changes to cancer care during the COVID-19 pandemic

Prof Richard Sullivan - Kings College London, London, UK & Dr Dorothy Lombe - Regional Cancer Treatment Service, Palmerston North, New Zealand
Silver linings: a qualitative study of desirable changes to cancer care during the COVID-19 pandemic ( Prof Richard Sullivan - Kings College London, London, UK & Dr Dorothy Lombe - Regional Cancer Treatment Service, Palmerston North, New Zealand )
15 Dec 2021

Glow study: MRD outcomes after fixed-duration Ibr+Ven versus Clb+O for first-line treatment of CLL in elderly or unfit patients

Dr Arnon Kater - Amsterdam UMC, Amsterdam, Netherlands
Glow study: MRD outcomes after fixed-duration Ibr+Ven versus Clb+O for first-line treatment of CLL in elderly or unfit patients ( Dr Arnon Kater - Amsterdam UMC, Amsterdam, Netherlands )
14 Dec 2021

Tisagenlecleucel shows no EFS improvement on standard of care in 2L for aggressive B-cell NHL

Dr Michael Bishop - University of Chicago, Chicago, USA
Tisagenlecleucel shows no EFS improvement on standard of care in 2L for aggressive B-cell NHL ( Dr Michael Bishop - University of Chicago, Chicago, USA )
14 Dec 2021

Integrated genomic analysis identifies UBTF tandem duplications as a subtype-defining lesion in paediatric AML

Dr Masayuki Umeda - St. Jude Children's Research Hospital, San Francisco, USA
Integrated genomic analysis identifies UBTF tandem duplications as a subtype-defining lesion in paediatric AML ( Dr Masayuki Umeda - St. Jude Children's Research Hospital, San Francisco, USA )
14 Dec 2021

Asciminib found to be safe and effective for heavily pretreated patients with chronic myeloid leukaemia in chronic phase

Dr Michael Mauro - Memorial Sloan Kettering Cancer Center, New York, USA
Asciminib found to be safe and effective for heavily pretreated patients with chronic myeloid leukaemia in chronic phase ( Dr Michael Mauro - Memorial Sloan Kettering Cancer Center, New York, USA )
14 Dec 2021

Long-term OS benefit with oral azacitidine for acute myeloid leukaemia in first remission after intensive chemo

Prof Andrew Wei - Monash University, Melbourne, Australia
Long-term OS benefit with oral azacitidine for acute myeloid leukaemia in first remission after intensive chemo ( Prof Andrew Wei - Monash University, Melbourne, Australia )
13 Dec 2021

Allogeneic haematopoietic cell transplantation in adults with Ph-like ALL

Dr Ibrahim Aldoss - City of Hope, Duarte, USA
Allogeneic haematopoietic cell transplantation in adults with Ph-like ALL ( Dr Ibrahim Aldoss -  City of Hope, Duarte, USA )
13 Dec 2021